shortagewatch

Home / Hydrochlorothiazide / Australia

AU ATC C03AA03 · updated 2 Nov 2026

Hydrochlorothiazide shortage in Australia

Is there a Hydrochlorothiazide shortage in Australia?

Yes. As of 2 Nov 2026, 7 Hydrochlorothiazide products are reported short in Australia, the first since 15 Nov 2024. The company estimate for the return is 18 Dec 2026 (latest 30 Apr 2027). Main reason: not stated.

Also short in United States, Canada. All countries.

Affected products in Australia

CountryProductCompanySinceExpected backReason
AUAVSARTAN HCT 300/25 irbesartan 300 mg and hydrochlorothiazide 25 mg tablets blister pack15 Nov 202430 Apr 2027Not stated
AUAVSARTAN HCT 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablets blister pack11 Jul 202530 Apr 2027Not stated
AUPHARMACOR OLMESARTAN HCTZ 40/25 olmesartan medoxomil and hydrochlorothiazide 40/25 mg tablet blister pack14 May 2026not givenNot stated
AUDILART HCT 80/12.5 mg valsartan 80 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack10 Jul 202618 Dec 2026Not stated
AUDILART HCT 160/25 mg valsartan 160 mg/hydrochlorothiazide 25 mg film-coated tablet blister pack13 Aug 202618 Dec 2026Not stated
AUDILART HCT 160/12.5 mg valsartan 160 mg/ hydrochlorothiazide 12.5 mg film-coated tablet blister pack limited4 Sep 202618 Dec 2026Not stated
AUDILART HCT 320/25 mg valsartan 320 mg/ hydrochlorothiazide 25 mg film-coated tablet blister pack limited21 Sep 202618 Dec 2026Not stated

Source

Therapeutic Goods Administration (TGA), Medicine Shortage Reports Database. Official list. National shortages of reportable medicines, current and anticipated within six months; one row per product.